brentuximab,doxorubicin hydrochloride,dacarbazine,filgrastim,pegfilgrastim,nivolumab,vinblastine sulfate
seagen,amgen,bms
['brentuximab', 'hodgkin', 'lymphoma', 'nivolumab', 'nivo', 'vedo', 's1826', ' vedo']
don't miss the #asco23 plenary session presentation s1826, a randomized study of nivolumab(n)-avd versus brentuximab vedotin(bv)-avd in advanced stage (as) classic hodgkin lymphoma (hl) , 2:53 pm - 3:05 pm cdt this afternoon! learn more: 
Official Twitter account of NCI's Cancer Therapy Evaluation Program, providing updates to our trials research community. Part of @NIH. Privacy: https://t.co/9Aox3geiD8